Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-14558.34%
operating margin TTM
-16074.72%
revenue TTM
1.10 Million
revenue per share TTM
0.06$
valuation ratios | |
|---|---|
| pe ratio | -0.30 |
| peg ratio | 0.00 |
| price to book ratio | 0.37 |
| price to sales ratio | 53.99 |
| enterprise value multiple | -0.90 |
| price fair value | 0.37 |
profitability ratios | |
|---|---|
| gross profit margin | -5524.73% |
| operating profit margin | -16074.72% |
| pretax profit margin | -14716.92% |
| net profit margin | -14558.34% |
| return on assets | -92.49% |
| return on equity | -116.12% |
| return on capital employed | -114.92% |
liquidity ratio | |
|---|---|
| current ratio | 3.30 |
| quick ratio | 3.30 |
| cash ratio | 3.17 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 290.71 |
| days of payables outstanding | 59.10 |
| cash conversion cycle | 231.61 |
| receivables turnover | 1.26 |
| payables turnover | 6.18 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | -2,340.37 |
| cash flow to debt ratio | -414.72 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.92 |
| cash per share | 0.52 |
| operating cash flow per share | -0.92 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -414.72 |
| short term coverage ratios | -414.72 |
| capital expenditure coverage ratio | -2,485,595.56 |
Frequently Asked Questions
When was the last time Bionomics Limited (NASDAQ:BNOX) reported earnings?
Bionomics Limited (BNOX) published its most recent earnings results on 14-11-2024.
What is Bionomics Limited's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Bionomics Limited (NASDAQ:BNOX)'s trailing twelve months ROE is -116.12%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Bionomics Limited (BNOX) currently has a ROA of -92.49%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BNOX's net profit margin stand at?
BNOX reported a profit margin of -14558.34% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BNOX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.30 in the most recent quarter. The quick ratio stood at 3.30, with a Debt/Eq ratio of 0.00.